Nohla Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Out of Business

Nohla Therapeutics General Information

Description

Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical diseases. The company's products are based on a unique umbilical cord blood expansion platform, providing doctors the functional support of bone marrow in response to each patient's unique blood-production needs, without any requirement for HLA matching.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1600 Fairview Avenue East
  • Suite 100
  • Seattle, WA 98102
  • United States
+1 (206)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 1600 Fairview Avenue East
  • Suite 100
  • Seattle, WA 98102
  • United States
+1 (206)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nohla Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Nov-2019 Completed Out of Business
4. Early Stage VC (Series B) 12-Jul-2018 Completed Clinical Trials - Phase 2
3. Grant 28-Sep-2017 Completed Startup
2. Early Stage VC (Series A) 29-Nov-2016 $43.5M $64.5M Completed Startup
1. Corporate 24-Dec-2015 $21M $21M Completed Startup
To view Nohla Therapeutics’s complete valuation and funding history, request access »

Nohla Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A1
To view Nohla Therapeutics’s complete cap table history, request access »

Nohla Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical
Biotechnology
Seattle, WA
43 As of 2018

Utrecht, Netherlands
 

Lyon, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nohla Therapeutics Competitors (58)

One of Nohla Therapeutics’s 58 competitors is Gadeta, a Formerly VC-backed company based in Utrecht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gadeta Formerly VC-backed Utrecht, Netherlands
Phaxiam Formerly VC-backed Lyon, France
TScan Therapeutics Formerly VC-backed Waltham, MA
NexImmune Formerly VC-backed Gaithersburg, MD
Kite Pharma Formerly VC-backed Santa Monica, CA
You’re viewing 5 of 58 competitors. Get the full list »

Nohla Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nohla Therapeutics FAQs

  • When was Nohla Therapeutics founded?

    Nohla Therapeutics was founded in 2015.

  • Where is Nohla Therapeutics headquartered?

    Nohla Therapeutics is headquartered in Seattle, WA.

  • What is the size of Nohla Therapeutics?

    Nohla Therapeutics has 43 total employees.

  • What industry is Nohla Therapeutics in?

    Nohla Therapeutics’s primary industry is Biotechnology.

  • Is Nohla Therapeutics a private or public company?

    Nohla Therapeutics is a Private company.

  • What is Nohla Therapeutics’s current revenue?

    The current revenue for Nohla Therapeutics is .

  • How much funding has Nohla Therapeutics raised over time?

    Nohla Therapeutics has raised $120M.

  • Who are Nohla Therapeutics’s competitors?

    Gadeta, Phaxiam, TScan Therapeutics, NexImmune, and Kite Pharma are some of the 58 competitors of Nohla Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »